ZWZanxin Wang

Zanxin Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zanxin Wang has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Bailang Chen

    Department of Cardiovascular Surgery, The University of Hong Kong-Shenzhen Hospital

    5 shared publications
  • Minxin Wei

    Division of Cardiovascular Surgery, Cardiac and Vascular Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China

    5 shared publications
  • Haocheng Lu

    Department of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China

    3 shared publications
  • Xianmian Zhuang

    Department of Cardiovascular Surgery, The University of Hong Kong-Shenzhen Hospital

    3 shared publications
  • Chi Zhang

    Department of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, SUSTech Homeostatic Medicine Institute, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, 518055, China

    2 shared publications
  • Minxin Wei

    Department of Cardiovascular Surgery, The University of Hong Kong-Shenzhen Hospital

    2 shared publications

Latest Publications

  • Open Access

    Intraoperative measurement of the ascending aortic diameter at the onset of aortic dissection

    by Bailang Chen, Xianmian Zhuang, Rui Zhang, Zanxin Wang, Minxin Wei

    Background: Although prior studies have associated aortic size with dissection risk, none have corrected for dissection-related aortic expansion. This study aimed to establish a measurement approach to determine the ascending aortic diameter before dissection. Methods: The samples of dissected ascending aortas were obtained from 36 patients at the time of their operation. In this study, the intimal lumen diameter measured at its maximal stretching state was used as a reliable surrogate for the pre-dissection aortic diameter. Subsequently, the relationship between this surrogate and the aortic diameter measured on post-dissection CT at the corresponding levels was further analyzed. Results: Using this method, the pre-dissection ascending aortic diameter was measured as 37.5 ± 6.6 mm, whereas the post-dissection CT measurement at the same level increased to 43.9 ± 7.0 mm. After excluding patients with non-A-non-B aortic dissection, the mean ascending aortic diameter increased by approximately 20% after dissection compared with the pre-dissection value, corresponding to an absolute increase of 7.5 mm in diameter. Conclusions: Although aortic diameter remains a robust indicator for prophylactic surgery in the study population, acute aortic dissection is seldom associated with true ascending aortic aneurysms and occurs with normal or near-normal aortic dimensions in most patients. When dissection occurs in the setting of a small aortic diameter, it likely reflects a profound functional vulnerability of the aortic tissue to catastrophic aortic events.

  • Integrative genetic analyses for drug repurposing identify emodin as a candidate modulator of STAT3 signaling in abdominal aortic aneurysm

    by Yingjie Liu, Zhijun Xu, Lin Deng, Chi Zhang, Xiao Ruan, Linlu Zhao, Ying Yang, Zanxin Wang, Haocheng Lu

  • Open Access

    Role of Caveolae and Caveolin in Vascular Physiology and Pathology

    by Chi Zhang, Wenting Hu, Jiaye Zhang, Zanxin Wang, Haocheng Lu

    Caveolae, 50–100 nm cholesterol‐rich plasma membrane invaginations, serve as critical signaling hubs in vascular cells. These structures—scaffolded by caveolin proteins (CAV1, CAV2, CAV3) and regulated by Cavins—orchestrate membrane dynamics, mechanotransduction, and lipid trafficking in endothelial cells, smooth muscle cells, and macrophages. In vascular physiology, caveolae modulate vascular tone, regulate lipoprotein metabolism, and mediate mechanosensation. In pathology, caveolae are implicated in atherosclerosis, pulmonary hypertension, and diabetic vasculopathy. This review synthesizes advances in caveolae biology, highlighting their roles in vascular homeostasis and disease. We propose caveolae‐targeted therapies as promising strategies for cardiovascular disorders, contingent on resolving context‐dependent signaling complexity.


  • Open Access

    Case Report: A FBN1 frameshift-and-nonsense mutation and aortic dissection in Marfan syndrome

    by Chao Su, Linjun Zeng, Haocheng Lu, Zanxin Wang, Minxin Wei

    Background: Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder primarily affecting the cardiovascular, ocular, and skeletal systems. Cardiovascular complications are the leading cause of mortality in MFS. Mutations in the FBN1 gene, which encodes fibrillin-1, a critical extracellular matrix protein, are the predominant cause of the disorder.Case presentation: On March 11, 2024, we diagnosed a 30-year-old female proband with MFS based on the revised Ghent criteria, presenting with aortic root aneurysm, aortic dissection, multiple skeletal abnormalities, and a family history of MFS. Whole-exome sequencing followed by Sanger sequencing confirmation identified a novel inherited insertion mutation (c.4991dupA) in exon 40 of the FBN1 gene. We performed valve-sparing aortic root replacement (David Procedure) and total aortic arch replacement using a tetrafurcated graft, along with the implantation of a specially designed frozen elephant trunk in the descending aorta (Sun's Procedure). Postoperatively, the patient underwent biweekly clinical follow-ups for three months. No treatment-related adverse events were reported during the monitoring period.Conclusion: The diagnosis of MFS requires an integrated approach, combining clinical manifestations, imaging studies, and genetic analysis. This novel mutation is associated with severe skeletal manifestations and life-threatening cardiovascular abnormalities, underscoring its clinical relevance. Its association with aggressive phenotypes enhances genotype-phenotype correlations. Importantly, these findings highlight the imperative need for early intervention in high-risk individuals by bridging genetic discovery to clinical practice.


    • 1 March 2025
      • Vol. 37  (3) , 225-231

    [Aortic dissection and vascular smooth muscle cell apoptosis: in-depth exploration of their relationship and potential therapeutic strategies].

    by Haodong Zhou, Zanxin Wang

    Aortic dissection (AD) is a life-threatening cardiovascular disease characterized a tear in the aortic intima, which leads to the formation of two separate channels within the aortic wall due to blood flow. The mortality rate of AD is high, especially when dissection ruptures, as it can rapidly trigger acute cardiac and vascular complications, ultimately leading to death. Therefore, understanding the pathogenesis of AD and identifying potential therapeutic strategies is of critical clinical importance. Vascular smooth muscle cell (VSMC) play a central role in the structural and functional integrity of the aortic wall, and dysfunction of VSMC is closely associated with the development of AD. Recent studies suggest that the functional alterations of VSMC involve multiple mechanisms, including apoptosis, oxidative stress, and aberrant intracellular signaling, all of which play key roles in the disruption of the aortic wall structure. This review focuses on the role of VSMC in AD, particularly the specific involvement of VSMC apoptosis in the progression of AD, and further explores therapeutic strategies targeting the pathological processes of VSMC in AD, such as the inhibition of inflammatory mediators and oxidative stress. Despite some progress in current treatments, effectively intervening in the pathological progression of VSMC remains a significant challenge. Future research will further investigate these mechanisms, providing new insights and strategies for the treatment of AD. Studying the role of VSMC in AD is crucial for the development of novel therapeutic approaches.

  • Open Access

    Staging reinterventions for remodeling of residual aortic dissection: a single-center retrospective study

    by Bailang Chen, Kunpeng Huang, Xianmian Zhuang, Zanxin Wang, Minxin Wei

    Objective: Inadequate remodeling of residual aortic dissection (RAD) following repair of Stanford A or B aortic dissections has been identified as a significant predictor of patient mortality. This study evaluates the short- to mid-term outcomes of staged reinterventions for RAD at a single center with prospective follow-up.Methods: Data were retrospectively collected from patients with RAD who underwent staged reinterventions or received none-surgery treatment in the Cardiovascular Surgery Department of our hospital between July 2019 and December 2021. The cohort included 54 patients with residual distal aortic dissection post-primary surgery, comprising 28 who underwent open surgery and 26 who received thoracic endovascular aortic repair (TEVAR). Patients were divided into two groups: those who underwent staged stent interventions for distal dissection [staged reintervention (SR) group] and those who did not undergo surgery (non-surgery group). For the SR group, second or third staged stent interventions were performed. The study assessed distal remodeling of aortic dissection between the groups, focusing on endpoints such as mortality (both general and aortic-specific), occurrences of visceral branch occlusion, necessity for further interventions, and significant adverse events. Morphological changes were analyzed to determine the therapeutic impact.Results: The study encompassed 54 participants, with 33 in the SR group and 21 in the non-surgical control group. Baseline demographics and clinical characteristics were statistically comparable across both groups. During an average follow-up of 31.5 ± 7.0 months, aortic-related mortality was 0% in both groups; all-cause mortality was 3% (one case) and 5% (one case) in the SR and control groups, respectively, with no statistically significant difference noted. In the SR group, a single patient experienced complications, including renal artery thrombosis, leading to diminished blood flow. An increased true lumen (TL) area and a decreased false lumen area at various aortic planes were observed in the SR group compared to the control group.Conclusion: The staged reintervention strategy for treating RAD is safe and provides promising early results.


  • Open Access

    Intravenous infusion port catheter misplaced into the right subclavian artery

    by Bailang Chen, Weihong Yang, Zanxin Wang, Minxin Wei


  • Open Access

    Efficacy of endovascular repair in the treatment of retrograde ascending aortic intramural haematoma

    by Bailang Chen, Rui Zhang, Haibing Liu, Yao Chen, Zanxin Wang, Minxin Wei

    The current treatment for retrograde ascending aortic intramural hematoma (RAIMH) remains challenging. This study aims to summarize the short-term results of endovascular repair in the treatment of retrograde ascending aortic intramural hematoma. Between June 2019 and June 2021, 21 patients (16 males and 5 females) with a retrograde ascending aortic intramural hematoma, aged 53 ± 14years, received an endovascular repair in our hospital. All cases involved an ascending aortic or aortic arch intramural hematoma. 15 patients had an ulcer on the descending aorta combined with an intramural hematoma in the ascending aorta and 6 patients had typical dissection changes on the descending aorta combined with an intramural hematoma in the ascending aorta. All patients had a successful endovascular stent-graft repair, with 10 cases operated on in the acute phase (<14 days) and 11 cases in the chronic phase (14–35 days). A single-branched aortic stent graft system was implanted in 10 cases, a straight stent in 2 cases, and a fenestrated stent in 9 cases. All surgeries were technically successful. One of the patients developed a new rupture 2 weeks after surgery and was converted to a total arch replacement. No perioperative stroke, paraplegia, stent fracture or displacement, limb or abdominal organ ischemia occurred. The intramural hematomas started being absorbed on CT angiography images before discharge. There was no incidence of postoperative 30-day mortality, and the intramural hematomas in the ascending aorta and aortic arch were fully or partly absorbed. Endovascular repair of retrograde ascending aortic intramural hematoma was shown to be safe and effective, and correlated with favorable short-term results.

  • Open Access

    Endothelial colony-forming cell-derived exosomal miR-21-5p regulates autophagic flux to promote vascular endothelial repair by inhibiting SIPL1A2 in atherosclerosis

    by Xiao Ke, Zhiyong Liao, Xinlin Luo, Jun-Qiu Chen, Ming Deng, Yiteng Huang, Zanxin Wang, Minxin Wei

    Background: Percutaneous transluminal coronary angioplasty (PTCA) represents an efficient therapeutic method for atherosclerosis but conveys a risk of causing restenosis. Endothelial colony-forming cell-derived exosomes (ECFC-exosomes) are important mediators during vascular repair. This study aimed to investigate the therapeutic effects of ECFC-exosomes in a rat model of atherosclerosis and to explore the molecular mechanisms underlying the ECFC-exosome-mediated effects on ox-LDL-induced endothelial injury.Methods: The effect of ECFC-exosome-mediated autophagy on ox-LDL-induced human microvascular endothelial cell (HMEC) injury was examined by cell counting kit-8 assay, scratch wound assay, tube formation assay, western blot and the Ad-mCherry-GFP-LC3B system. RNA-sequencing assays, bioinformatic analysis and dual-luciferase reporter assays were performed to confirm the interaction between the miR-21-5p abundance of ECFC-exosomes andSIPA1L2in HMECs. The role and underlying mechanism of ECFC-exosomes in endothelial repair were explored using a high-fat diet combined with balloon injury to establish an atherosclerotic rat model of vascular injury. Evans blue staining, haematoxylin and eosin staining and western blotting were used to evaluate vascular injury.Results: ECFC-exosomes were incorporated into HMECs and promoted HMEC proliferation, migration and tube formation by repairing autophagic flux and enhancing autophagic activity. Subsequently, we demonstrated that miR-21-5p, which is abundant in ECFC-exosomes, binds to the 3’ untranslated region of SIPA1L2 to inhibit its expression, and knockout of miR-21-5p in ECFC-exosomes reversed ECFC-exosome-decreased SIPA1L2 expression in ox-LDL-induced HMEC injury. Knockdown of SIPA1L2 repaired autophagic flux and enhanced autophagic activity to promote cell proliferation in ox-LDL-treated HMECs. ECFC-exosome treatment attenuated vascular endothelial injury, regulated lipid balance and activated autophagy in an atherogenic rat model of vascular injury, whereas these effects were eliminated with ECFC-exosomes with knockdown of miR-21-5p.Conclusions: Our study demonstrated that ECFC-exosomes protect against atherosclerosis- or PTCA-induced vascular injury by rescuing autophagic flux and inhibiting SIAP1L2 expression through delivery of miR-21-5p.